Skip to Main Content

Paper Details

Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation.
Int J Radiat Oncol Biol Phys
3
2022
BRPC, Capecitabine, LAPC, Locally Advanced and, Paclitaxel, Pancreatic Cancer, Patients, borderline-resectable pancreatic cancer, capecitabine, nab, nab-paclitaxel, paclitaxel, pancreatic ductal adenocarcinoma, patients
Author NameAffiliation
Shubham PantThe University of Texas MD Anderson Cancer Center
Grace L SmithThe University of Texas, MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2